This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sysco (SYY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Sysco (SYY) closed at $85.76, marking a +0.73% move from the previous day.
The Estee Lauder Companies (EL) Beats on Earnings in Q3
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter fiscal 2022 sales and earnings rise year over year on growth in every product category. Management lowered fiscal 2022 view.
Molson Coors (TAP) Q1 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Molson Coors' (TAP) Q1 results reflect continued progress on its revitalization plan, premiumization efforts and strength in core brands. However, inflationary pressure remains concerning.
Clorox (CLX) Q3 Earnings & Sales Beat on Solid Demand
by Zacks Equity Research
Clorox (CLX) Q3 results gained from solid demand, pricing actions and cost savings efforts. However, the ongoing inflationary pressures led to lowered bottom line view for fiscal 2022.
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, The Chefs' Warehouse, Pilgrim's Pride, McCormick & Company and Sysco
by Zacks Equity Research
Archer-Daniels-Midland, The Chefs' Warehouse, Pilgrim's Pride, McCormick & Company and Sysco have been included in this Analyst Blog.
Clorox (CLX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 35.05% and 0.04%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Picks for May From Best S&P 500 Sectors in Ruthless April
by Nalak Das
We have narrowed our search to five consumer staples stocks that have solid growth potential for the rest of 2022. These are: PPC, ADM, CHEF, MKC and SYY.
Keurig Dr Pepper (KDP) Q1 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper (KDP) reports solid sales performance for first-quarter 2022 on gains from its robust brand portfolio. KDP raises sales view for the year.
Colgate (CL) Meets Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Colgate's (CL) Q1 results reflect soft bottom-line performance on higher raw material and logistics costs despite the increased top line. Margins remain soft.
Should iShares Morningstar MidCap ETF (IMCB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCB
Hershey (HSY) Beats on Q1 Earnings & Sales, Raises 2022 View
by Zacks Equity Research
Hershey's (HSY) first-quarter 2022 results reflect higher earnings and sales on growth across all segments. Management raises 2022 guidance.
Helen of Troy (HELE) Q4 Earnings Top Estimates & Increase Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter results reflect higher earnings and sales, including strength in the organic business and contributions from the Osprey acquisition.
Altria (MO) Q1 Earnings & Revenues Top Estimates, Pricing Aids
by Zacks Equity Research
Altria Group's (MO) first-quarter 2022 results reflect increased revenues and earnings. Pricing remains an upside, though shipment volumes appear soft.
Pilgrim's Pride (PPC) Q1 Earnings Beat, Sales Improve Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q1 earnings benefit from strength across the brand portfolio, products and geographies. Sales gain from growth in Mexico and Europe, and the U.S. operations.
Kraft Heinz (KHC) Q1 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
The Kraft Heinz Company's (KHC) first-quarter 2022 results reflect lower earnings and sales. Nevertheless, management raises the 2022 organic net sales view.
Inter Parfums' (IPAR) Q1 Sales Solid, Brand Strength Key Driver
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in first-quarter 2022. The company's largest and mid-sized brands deliver solid sales performance.
Mondelez (MDLZ) Q1 Earnings Top Estimates, Cost Woes Linger
by Zacks Equity Research
Mondelez's (MDLZ) first-quarter 2022 results reflect higher earnings and revenues, with the latter gaining on buyouts and solid organic revenues. Management expects input cost inflation to persist.
Here's How Much You'd Have If You Invested $1000 in Sysco a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Should iShares Morningstar MidCap Value ETF (IMCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCV
Kimberly-Clark (KMB) Q1 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2022 earnings decline year over year. Nevertheless, sales increased on growth across all segments.
Philip Morris (PM) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2022 results reflect higher earnings and revenues, with favorable pricing variance being an upside.
Pilgrim's Pride (PPC) Gains on Solid Performance, Growth Efforts
by Zacks Equity Research
Pilgrim's Pride (PPC) is benefiting from the foodservice business rebound. The company's customer-centric approach supports its unique offerings.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Sysco (SYY)
by Zacks Equity Research
Sysco (SYY) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Archer Daniels' (ADM) Strategic Efforts & Nutrition Unit Aid
by Zacks Equity Research
Archer Daniels (ADM) effortlessly advances on its growth strategies that assure to optimize the core, drive efficiencies, innovate and expand strategically.
Archer Daniels (ADM) Expands Alternative Protein Production
by Zacks Equity Research
Archer Daniels (ADM) announces plans to invest roughly $300 million to expand its Decatur, IL, alternative protein production.